Senti Biosciences Inc at Chardan Genetic Medicines Conference Transcript
Introducing our next guest, we have Dr. Tim Lu, Co-Founder and CEO; and Dr. Deb Knobelman, CFO and Head of Corporate Development of Senti Bio. The format for this session is a fireside chat and thank you both for joining us today. To begin with, let's start with a brief overview of Senti and hitting the highlights on the recent updates and upcoming catalysts.
So thanks a lot for that, happy to be here. Senti, at the heart of it, is a what we call gene circuits company, which means that we essentially are designing multifunctional capabilities into cell and gene therapies broadly. So our products are really focused on how to endow cells with more precise targeting, control, as well as greater efficacy. And we do this by essentially introducing multi-gene constructs into living cells and programming those genes in a way that allows us to achieve dynamic precision functionality. We've basically been focused internally on developing a pipeline of oncology programs,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
